1. Home
  2. PTIX vs CNEY Comparison

PTIX vs CNEY Comparison

Compare PTIX & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • CNEY
  • Stock Information
  • Founded
  • PTIX 1994
  • CNEY 2018
  • Country
  • PTIX United States
  • CNEY China
  • Employees
  • PTIX N/A
  • CNEY N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • CNEY Major Chemicals
  • Sector
  • PTIX Health Care
  • CNEY Industrials
  • Exchange
  • PTIX Nasdaq
  • CNEY Nasdaq
  • Market Cap
  • PTIX 2.0M
  • CNEY 2.1M
  • IPO Year
  • PTIX 2016
  • CNEY 2021
  • Fundamental
  • Price
  • PTIX $0.42
  • CNEY $0.13
  • Analyst Decision
  • PTIX
  • CNEY
  • Analyst Count
  • PTIX 0
  • CNEY 0
  • Target Price
  • PTIX N/A
  • CNEY N/A
  • AVG Volume (30 Days)
  • PTIX 324.0K
  • CNEY 504.6K
  • Earning Date
  • PTIX 05-14-2025
  • CNEY 01-01-0001
  • Dividend Yield
  • PTIX N/A
  • CNEY N/A
  • EPS Growth
  • PTIX N/A
  • CNEY N/A
  • EPS
  • PTIX N/A
  • CNEY N/A
  • Revenue
  • PTIX N/A
  • CNEY $50,957,974.00
  • Revenue This Year
  • PTIX N/A
  • CNEY N/A
  • Revenue Next Year
  • PTIX N/A
  • CNEY N/A
  • P/E Ratio
  • PTIX N/A
  • CNEY N/A
  • Revenue Growth
  • PTIX N/A
  • CNEY N/A
  • 52 Week Low
  • PTIX $0.18
  • CNEY $0.12
  • 52 Week High
  • PTIX $1.87
  • CNEY $1.60
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 67.76
  • CNEY 32.47
  • Support Level
  • PTIX $0.18
  • CNEY $0.12
  • Resistance Level
  • PTIX $0.28
  • CNEY $0.14
  • Average True Range (ATR)
  • PTIX 0.04
  • CNEY 0.01
  • MACD
  • PTIX 0.01
  • CNEY 0.00
  • Stochastic Oscillator
  • PTIX 62.39
  • CNEY 28.97

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

Share on Social Networks: